Can a Two-Session 'Acceptance' therapy keep HIV patients in treatment?
NCT ID NCT04201288
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a short, two-session therapy called Acceptance-Based Behavior Therapy (ABBT) to help people newly diagnosed with HIV stay committed to their medical care. The therapy teaches coping skills to overcome barriers like fear of disclosure. Researchers tracked whether participants attended at least three medical visits in a year and achieved an undetectable viral load. The trial enrolled 38 adults and compared ABBT to standard HIV education.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Acceptance-Based Behavior Therapy (ABBT)
What this could lead to
If it works, this could offer a simple, short-term behavioral tool to help people newly diagnosed with HIV stay engaged in medical care and improve their health outcomes.
What could go wrong
This is a very small, early-stage study with only 38 participants, so results may not apply broadly. The intervention is behavioral, not a medical treatment, and its impact on long-term viral suppression is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brown University
Providence, Rhode Island, 02912, United States